Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Harbour BioMed (Guangzhou) Co. Ltd
Scientific Title
A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of HBM4003 in Subjects With Advanced Solid Tumors